Methyl Isobutyl Ketone

Methyl Isobutyl Ketone

SCHEMBL358566

CC(=O)CC(C)C.O

nearest known ligand 0.00

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ABCC9ABL1ACEACHEACVR1ADORA1ADORA2AADORA2BADORA3ADRA1AADRA1BADRA1DADRA2AADRA2BADRA2CADRB1ADRB2ADRB3AGTR1ALOX5ATP4AATP4BBCRBTKCACNA1ACACNA1BCACNA1CCACNA1DCACNA1ECACNA1FCACNA1GCACNA1HCACNA1ICACNA1SCACNA2D1CACNA2D2CACNA2D3CACNA2D4CACNB1CACNB2CACNB3CACNB4CACNG1CACNG2CACNG3CACNG4CACNG5CACNG6CACNG7CACNG8CALCRLCFBCHRM1CHRM2CHRM3CHRM4CHRM5CHRNA1CHRNB1CHRNDCHRNECHRNGCRBNCUL4ACXCR1CXCR2DDB1DDCDHFRDPP4DRD2DRD3DRD4EGFRERBB2ERBB4ESR1ESR2FDPSFKBP1AFLT1FLT3FLT4GARTGHSRGRIA1GRIA2GRIA3GRIA4GRIK1GRIK2GRIK3GRIK4GRIK5GRIN2AGSK3AGSK3BHDAC1HDAC10HDAC11HDAC2HDAC3HDAC4HDAC5HDAC6HDAC7HDAC8HDAC9HRH1HTR1AHTR1BHTR1DHTR1EHTR1FHTR2AHTR2BHTR2CHTR3AHTR3BHTR3CHTR3DHTR3EHTR4HTR5AHTR6HTR7IDH1IDH2IMPA1ITGA2BITGB3JAK1JAK2JAK3KCNJ11KCNK3KCNK9KDRKITMEN1METMMP1MMP13MMP7MMP8NANOD2NS5bODC1OPG057OPRD1OPRK1OPRM1PPARP1PARP2PDE3APDE3BPDE4APDE4BPDE4CPDE4DPDGFRBPIK3CAPIK3CBPIK3CDPIK3CGPIK3R1PIK3R2PIK3R3PIK3R5PKLRPPARDPPATPTGS1PTGS2RBX1ROCK1ROCK2RRM1RRM2RRM2BSCN10ASCN11ASCN1ASCN2ASCN3ASCN4ASCN5ASCN7ASCN8ASCN9ASCNN1ASCNN1BSCNN1GSIGMAR1SLC10A2SLC5A2SLC6A2SLC6A3SLC6A4SLC9A3SYKTACR1THRATHRBTOP1TUBA1ATUBA1BTUBA1CTUBA3CTUBA3ETUBA4ATUBBTUBB1TUBB2ATUBB2BTUBB3TUBB4ATUBB4BTUBB6TUBB8TYK2TYMSVDRampCblablaT-3blaT-4blaT-5blaT-6blaUOE-1dacAdacBdacCfolAfolPftsIgyrAgyrBileSmecAmrcAmrcBmrdAparCparEpbp2pbp4pbpApbpFrplArplBrplCrplDrplErplFrplIrplJrplKrplLrplMrplNrplOrplPrplQrplRrplSrplTrplUrplVrplWrplXrplYrpmArpmBrpmCrpmDrpmErpmE2rpmFrpmGrpmG1rpmG2rpmG3rpmHrpmIrpmJrpsArpsBrpsCrpsDrpsErpsFrpsGrpsHrpsIrpsJrpsKrpsLrpsMrpsNrpsOrpsPrpsQrpsRrpsSrpsTrpsUthyAykgMykgO

The experimentally established mechanism targets of Methyl Isobutyl Ketone. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 25 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119972145-A Bifunctional solid acid catalyst, preparation method thereof and method for preparing HMF from glucose 盐城工学院 2025-05-13 CN claimed
EP-4613272-A1 USE OF PYRIDINE DERIVATIVE WHICH IS TRPV1 ANTAGONIST Shionogi & Co., Ltd (JP) 2025-09-10 EP disclosed
US-20250073226-A1 USE OF OPIOID FOR TREATMENT OF AUTISM SPECTRUM DISORDERS OSAKA UNIVERSTIY (JP) 2025-03-06 US disclosed
WO-2024262491-A1 CRYSTAL OF NITROGEN-CONTAINING HETEROCYCLIC COMPOUND HAVING NRF2 ACTIVATION EFFECT 中外製薬株式会社 2024-12-26 WO disclosed
CN-118995848-A Method for synthesizing furfuryl amine by catalyzing biomass through chemical-biological coupling based on ternary deep eutectic solvent and application of method 常州大学 2024-11-22 CN disclosed
EP-4454649-A1 USE OF OPIOID FOR TREATMENT OF AUTISM SPECTRUM DISORDERS OSAKA UNIVERSITY (JP) 2024-10-30 EP disclosed
CN-114988996-B Process for separating and recycling recovery materials of MIBK light component tower 浙江镇洋发展股份有限公司 2024-05-17 CN disclosed
US-11958805-B2 Solid forms comprising an oxime ether compound, compositions and methods of use thereof NOVARTIS AG (CH) 2024-04-16 US disclosed
CN-115463684-A Bifunctional acidic SBA-15-based catalyst and preparation method thereof 东南大学 2022-12-13 CN disclosed
US-20200377454-A1 Solid Forms Comprising An Oxime Ether Compound, Compositions and Methods of Use Thereof NOVARTIS INTERNATIONAL PHARMACEUTICAL AG (CH) 2020-12-03 US disclosed
EP-0967221-B1 PROCESS FOR PREPARING PHARMACOLOGICALLY ACCEPTABLE SALTS OF N-(1(S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-L-ALANYL AMINO ACIDS KANEKA CORP (JP) 2005-05-25 EP disclosed
US-6713628-B2 BY-PRODUCT INHIBITION OF THE DIKETOPIPERAZINE DERIVATIVE BY CARRYING OUT IN AQUEOUS LIQUID A SERIES OF OPERATIONS UNDER GIVEN CONDITIONS IN THE SAME SOLVENT; MAKING ENALAPRIL MALEATE FOR EXAMPLE KANEKA CORPORATION (JP) 2004-03-30 US disclosed
US-6518436-B2 Condensing an amino acid and N-(1(S)-ethoxycarbonyl-3-phenylpropyl)-L-alanine-N-carboxy-anhydride; suppressing the by-product diketopiperazine derivative; making enalapril maleate KANEKA CORPORATION (JP) 2003-02-11 US disclosed
US-6335453-B1 BY-PROUDCT INHIBITION KANEKA CORPORATION (JP) 2002-01-01 US disclosed
EP-0967221-A1 PROCESS FOR PREPARING PHARMACOLOGICALLY ACCEPTABLE SALTS OF N-(1(S)-ETHOXYCARBONYL-3-PHENYLPROPYL)-L-ALANYL AMINO ACIDS KANEKA CORPORATION (JP) 1999-12-29 EP disclosed
US-5940307-A Method for predicting the tendency of a protein to form amphiphilic αβ structure THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1999-08-17 US disclosed
WO-1996018957-A9 A METHOD FOR PREDICTING PROTEIN STRUCTURE 1996-08-01 WO disclosed
WO-1996018957-A1 A METHOD FOR PREDICTING PROTEIN STRUCTURE THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (US) 1996-06-20 WO disclosed
US-4227996-A FROTH FLOTATION, POLYAMINE CATIONIC COLLECTOR CELANESE CORPORATION (US) 1980-10-14 US disclosed
US-4098844-A ADDITION COPOLYMER STABILIZED WITH AN ISOCYANATE-CONTAINING POLYMER DAI NIPPON TORYO CO., LTD. (JP) 1978-07-04 US disclosed